Suppr超能文献

白塞病中一种新型自身抗原Sip-1羧基末端区域的鉴定与特性分析

Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.

作者信息

Delunardo Federica, Conti Fabrizio, Margutti Paola, Alessandri Cristiano, Priori Roberta, Siracusano Alessandra, Riganò Rachele, Profumo Elisabetta, Valesini Guido, Sorice Maurizio, Ortona Elena

机构信息

Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Arthritis Res Ther. 2006;8(3):R71. doi: 10.1186/ar1940. Epub 2006 Apr 12.

Abstract

Given the lack of a serological test specific for Behçet's disease, its diagnosis rests upon clinical criteria. The clinical diagnosis is nevertheless difficult because the disease manifestations vary widely, especially at the onset of disease. The aim of this study was to identify molecules specifically recognized by serum autoantibodies in patients with Behçet's disease and to evaluate their diagnostic value. We screened a cDNA library from human microvascular endothelial cells with serum IgG from two patients with Behçet's disease and isolated a reactive clone specific to the carboxy-terminal subunit of Sip1 (Sip1 C-ter). Using ELISA, we measured IgG, IgM and IgA specific to Sip1 C-ter in patients with various autoimmune diseases characterized by the presence of serum anti-endothelial cell antibodies, such as Behçet's disease, systemic lupus erythematosus, systemic sclerosis and various forms of primary vasculitis, as well as in patients with diseases that share clinical features with Behçet's disease, such as inflammatory bowel disease and uveitis. IgM immunoreactivity to Sip1 C-ter was significantly higher in patients with Behçet's disease and in patients with primary vasculitis than in the other groups of patients and healthy subjects tested (P < 10-4 by Mann-Whitney test). ELISA detected IgG specific to Sip1 C-ter in sera from 11/56 (20%) patients with Behçet's disease, IgM in 23/56 (41%) and IgA in 9/54 (17%). No sera from patients with systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease, uveitis or healthy subjects but 45% of sera from patients with primary vasculitis contained IgM specific to Sip1 C-ter. Serum levels of soluble E-selectin, a marker of endothelial activation and inflammation, correlated with levels of serum IgM anti Sip-1 C-ter in patients with Behçet's disease (r = 0.36, P = 0.023). In conclusion, Sip1 C-ter is a novel autoantigen in Behçet's disease. IgM specific to Sip1 C-ter might be useful in clinical practice as an immunological marker of endothelial dysfunction in vasculitis.

摘要

鉴于缺乏针对白塞病的特异性血清学检测方法,其诊断依赖于临床标准。然而,临床诊断很困难,因为该病的表现差异很大,尤其是在疾病发作时。本研究的目的是鉴定白塞病患者血清自身抗体特异性识别的分子,并评估其诊断价值。我们用两名白塞病患者的血清IgG筛选了人微血管内皮细胞的cDNA文库,分离出一个对Sip1羧基末端亚基(Sip1 C-ter)特异的反应性克隆。我们使用酶联免疫吸附测定(ELISA)法,检测了各种以血清抗内皮细胞抗体为特征的自身免疫性疾病患者,如白塞病、系统性红斑狼疮、系统性硬化症和各种原发性血管炎患者,以及与白塞病有共同临床特征的疾病患者,如炎症性肠病和葡萄膜炎患者血清中对Sip1 C-ter特异的IgG、IgM和IgA。白塞病患者和原发性血管炎患者血清中对Sip1 C-ter的IgM免疫反应性显著高于其他受试患者组和健康受试者(曼-惠特尼检验P < 10-4)。ELISA法检测到56例白塞病患者中有11例(20%)血清中存在对Sip1 C-ter特异的IgG,23例(41%)存在IgM,54例中有9例(17%)存在IgA。系统性红斑狼疮、系统性硬化症、炎症性肠病、葡萄膜炎患者或健康受试者的血清中均未检测到对Sip1 C-ter特异的IgM,但45%的原发性血管炎患者血清中存在该IgM。可溶性E-选择素是内皮细胞活化和炎症的标志物,其血清水平与白塞病患者血清抗Sip-1 C-ter IgM水平相关(r = 0.36,P = 0.023)。总之,Sip1 C-ter是白塞病中的一种新型自身抗原。对Sip1 C-ter特异的IgM可能作为血管炎中内皮功能障碍的免疫标志物在临床实践中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c2/1526626/52551189ff6c/ar1940-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验